Renaissance Capital logo
IPO Center

Enzymotec

Priced, Nasdaq: ENZY

Develops lipid-based nutritional ingredients and medical foods.

Industry: Health Care

First Day Return: +29.7%

Develops lipid-based nutritional ingredients and medical foods.
IPO Data
IPO Date 09/26/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $62
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Migdal Ha'Emeq, Israel
Founded 1998
Employees at IPO 158
Website www.enzymotec.com

Enzymotec (ENZY) Performance

Follow Us

IPO ETFs

IPO Center

IPO Pro

IPO Intelligence

IPO Data

About Us

Important Disclosures
Renaissance Capital LLC is an SEC-registered investment adviser.
© 2026 Renaissance Capital LLC. All rights reserved.